NCT01697969

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.

Detailed description

Heidelberg Retina Tomograph (HRT) will be used to descriptively evaluate the corneal structures and assess the immune cell status of allergic conjunctivitis patients pre- and post-treatment with olopatadine 0.2% in relation to a normative database.

Conditions

• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Olopatadine hydrochloride ophthalmic solution, 0.2%

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2012-10-02
• Last updated: 2014-08-18
• Results posted: 2014-08-18

Locations

1 site across 1 country: United States